{
  "id": "mhgap#risk_safety_ebd9c12a",
  "content": "disorder. available), based on providing relevant information\ny TCAs should be avoided in older adults and in (e.g. possible side-effects, costs). Before prescribing\npeople diagnosed with glaucoma, heart conditions, medicines, discuss treatment options and any\nprostatism or other prostate conditions, or at risk of concerns the person has about taking medicines.\nthese conditions. y Explain rationale for prescribing and provide written\ny Consider increased risk of bleeding associated and verbal information on benefits and harms,\nwith SSRIs, particularly for older people or side-effects, drug interactions, the importance\npeople taking other medicines that can damage of taking medicines as prescribed and the likely\nthe gastrointestinal mucosa or interfere with time to improvement in symptoms.\nclotting (e.g. non-steroidal anti-inflammatory y Regularly review the effectiveness of the medicine\ndrugs [NSAIDs]). and side-effects with the person during the first\ny Antidepressants should be offered combined with three months of treatment and every three months\npsychological treatments, when sufficient resources afterwards. For adults who experience side-effects\nare available. after starting medicine, consider closer monitoring\nof their symptoms, reducing the dose of the\nResearch gaps\nmedicine or stopping the medicine gradually and\ny The majority of studies were conducted in offering alternative interventions.",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "risk_safety",
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General â€” Risk Safety disorder. available), based on providing relevant information\ny TCAs should be avoided in older adults and in (e.g. possible side-effects, costs). Before prescribing\npeople diagnosed with glaucoma, heart conditions, medicines, discuss treatment options and any\nprostatism or other prostate conditions, or at risk of concerns the person has about taking medicines.\nthese conditions. y Explain rationale for prescribing and provide written\ny Consider increased risk of bleeding associated and verbal information on benefits and harms,\nwith SSRIs, particularly for older people or side-effects, drug interactions, the importance\npeople taking other medicines that can damage of taking medicines as prescribed and the likely\nthe gastrointestinal mucosa or interfere with time to improvement in symptoms.\nclotting (e.g. non-steroidal anti-inflammatory y Regularly review the effectiveness of the medicine\ndrugs [NSAIDs]). and side-effects with the person during the first\ny Antidepressants should be offered combined with three months of treatment and every three months\npsychological treatments, when sufficient resources afterwards. For adults who experience side-effects\nare available. after starting medicine, consider closer monitoring\nof their symptoms, reducing the dose of the\nResearch gaps\nmedicine or stopping the medicine gradually and\ny The majority of studies were conducted in offering alternative interventions. Disorder. available), based on providing relevant information\ny tcas should be avoided in older adults and in (e.g."
}